OLIGODENDROGLIOMA
Clinical trials for OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for brain tumor patients when standard drug fails
Disease control Not yet recruitingThis study tests an experimental drug called safusidenib in people with a slow-growing brain tumor (IDH1-mutant glioma) whose tumor got worse while on the standard drug vorasidenib. Up to 40 participants take safusidenib pills twice daily to see if the tumor shrinks or stops grow…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Targeted pill aims to stall a common brain Tumor's growth
Disease control Not yet recruitingThis study tests whether the experimental drug safusidenib can slow or stop the growth of a type of slow-growing brain tumor called grade 2 glioma that has a specific genetic change (IDH1 mutation). Participants have had surgery but no other treatments like chemotherapy or radiat…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
AI-Powered radiation adjusts in real time to fight brain tumors
Disease control Not yet recruitingThis study tests a new way to deliver radiation therapy for people with diffuse glioma, a type of brain tumor. Instead of giving the same dose throughout treatment, doctors will use MRI and PET scans taken during treatment to adjust the radiation dose to target resistant areas an…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Personalized drug test aims to outsmart refractory brain tumors
Knowledge-focused Not yet recruitingThis study tests a lab technique called pharmacoscopy that analyzes a patient's tumor tissue to find which drugs might work best for them. It includes 40 adults with various aggressive or rare brain tumors that have not responded to standard treatments. The main goal is to see if…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Brain tumor study aims to clear up scans by shifting chemo timing
Knowledge-focused Not yet recruitingThis study tests giving chemotherapy before radiation for people with high-grade gliomas, a type of aggressive brain tumor. The goal is to see if this approach works well and makes MRI scans easier to read, since radiation can change how the brain looks. About 70 adults aged 18-8…
Matched conditions: OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: The Cooper Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC